http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018535243-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018535243-A
titleOfInvention Preparations for intravenous injection of tanilyxin
abstract The present invention relates to an improved formulation of tanilyxin in the hydrobromide form. This improved formulation can be an aqueous intravenous formulation containing tanilyxin or a lyophilized pharmaceutical solid composition containing tanilyxin that is reconstituted to provide a solution for intravenous administration.
priorityDate 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50995536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421276177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451560956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413152082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18526942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426812071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24780598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426169444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453750595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61636290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453112758
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44134763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413152062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263

Total number of triples: 54.